Table 4.
Completeness scoring system for PSA trends in prostate cancer pathways.
| Overall score | Biomarker | Frequency, n (%) | Average number of unique elements | ||
| Positioning | Substantiation | Description |
|
|
|
| S0 | 0 | N/Aa | No readings found. | 90/1904 (4.73) | 3.26 (SD .64) |
| S1 | 1 | N/Aa | One or more readings found before treatment (or no treatment), and no readings after. | 77/1904 (4.04) | 4.72 (SD 1.02) |
| S2 | 2 | N/Aa | One or more readings found after treatment, and no readings before. | 102/1904 (5.36) |
4.71 (SD 1.03) |
| S3 | 3 | No | One or more readings found before and after treatment. | 393/1904 (20.64) | 4.56 (SD .99) |
| S4 | 2 | Yes | One or more readings found after treatment and major biomarker variation explained. | 56/1904 (2.94) | 4.70 (SD .88) |
| S5 | 3 | Yes | One or more readings found before and after treatment and major biomarker variation explained. | 1186/1904 (62.29) | 4.80 (SD .92) |
aN/A=not applicable